IDENTIFICATION OF SUBSETS OF PATIENTS WITH GRAVES’DISEASE BY CLUSTER ANALYSIS

VALERIA STENSZKY, CS BALÁZS, L. KOZMA, SZ ROCHLITZ, J. C. BEAR, NADIR R. FARID

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

We have applied cluster analysis methods to forty‐nine laboratory and clinical characteristics (including 26 HLA‐A, B antigens) observed in 196 Graves’disease patients. Three subgroups could be identified: group I (seventy‐nine patients) had small goitres, low indices of autoimmunity and a tendency to remission with medical treatment; group IIa (twenty‐nine patients) had clinical and laboratory features of‘Hashitoxicosis'; Group IIb (eighty‐four patients) had a high incidence of ophthalmopathy, familial aggregation, marked evidence of autoaggression and a tendency to relapsing hyperthyroidism. The prevalence of HLA‐B8 was 8.9% in group I, 20.7% in group IIa and 86.9% in group IIb. This study demonstrates that Graves’disease can be subdivided using cluster analysis into clinically relevant subgroups which are further distinguished by their correlation with HLA‐B8. Possible immunological bases for these observed patterns are discussed.

Original languageEnglish
Pages (from-to)335-345
Number of pages11
JournalClinical Endocrinology
Volume18
Issue number4
DOIs
Publication statusPublished - Apr 1983

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'IDENTIFICATION OF SUBSETS OF PATIENTS WITH GRAVES’DISEASE BY CLUSTER ANALYSIS'. Together they form a unique fingerprint.

  • Cite this